5 Types of Hormone Therapy for Prostate Cancer

Hormone therapy for prostate cancer comes in several forms. Here are five.

First, GnRH agonists. They reduce testosterone production. Second, GnRH antagonists. They block GnRH directly, lowering testosterone faster. Third, antiandrogens. They block testosterone's effects. Fourth, abiraterone. It blocks androgen synthesis. Fifth, enzalutamide. It blocks androgen receptor signaling. These options are driving demand, as reflected in the Prostate Cancer Hormone Therapy Market.

For patients, these options mean choice. For providers, they mean more tools. For manufacturers, they mean growing demand. As research advances, more options will emerge.

People Also Ask

What is the difference between GnRH agonists and antagonists?
Agonists cause an initial testosterone surge, while antagonists lower testosterone immediately.

What are newer hormone therapies for prostate cancer?
Abiraterone and enzalutamide are newer agents that target androgen production or signaling.

Tags: #ProstateCancer #HormoneTherapy #GnRH #Abiraterone #Enzalutamide #PatientCare

Citeste mai mult